SCHEMBL24196449

SCHEMBL24196449

Fc1ncccc1-c1ccc(S)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.47
DHODH Q02127 4/20 0.43
MAPT P10636 4/20 0.43
CYP11B1 P15538 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
GSK3B P49841 1/20 0.39
CSNK1G2 P78368 1/20 0.39
MKNK1 Q9BUB5 2/20 0.38
MKNK2 Q9HBH9 2/20 0.38
GRIA2 P42262 2/20 0.37
CYP2C19 P33261 1/20 0.37
NAPRT Q6XQN6 1/20 0.37
KCNH2 Q12809 1/20 0.37
GRM5 P41594 1/20 0.35
BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3881160 0.83 CYP11B2 (0.50) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL31051044 0.81 DHODH (0.50) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL3876408 0.81 DHODH (0.50) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL18255779 0.80 CYP11B2 (0.47) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL3875252 0.80 CYP11B2 (0.55) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL22230844 0.80 CYP11B2 (0.47) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL12947927 0.80 DHODH (0.48) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL972023 0.80 CYP11B2 (0.47) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL29889660 0.79 MAPT (0.49) CYP11B2DHODHMAPTCYP11B1MAOA
SCHEMBL2489325 0.79 MAPT (0.49) CYP11B2DHODHMAPTCYP11B1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022008475-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIVERSITE CLAUDE BERNARD LYON 1 (FR) 2022-01-13 WO disclosed